{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:24:59Z","timestamp":1786994699561,"version":"build-2736575974"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience &amp; Biobehavioral Reviews"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.neubiorev.2024.105847","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T19:36:40Z","timestamp":1722973000000},"page":"105847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Management of neurological symptoms in Lesch-Nyhan disease: A systematic review"],"prefix":"10.1016","volume":"165","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0056-1761","authenticated-orcid":false,"given":"Oliwier","family":"Krajewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miko\u0142aj","family":"Opie\u0142ka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Urbanowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol","family":"Chojnowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Kochany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kacper","family":"Paw\u0142owski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagoda","family":"Tomaszewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godefridus J.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryszard T.","family":"Smole\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Mazurkiewicz-","family":"Be\u0142dzi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neubiorev.2024.105847_bib1","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3171\/2014.8.PEDS1451","article-title":"Lateralized effect of pallidal stimulation on self-mutilation in Lesch-Nyhan disease","volume":"14","author":"Abel","year":"2014","journal-title":"J. Neurosurg. Pediatr."},{"key":"10.1016\/j.neubiorev.2024.105847_bib2","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0278-5846(96)00059-0","article-title":"Risperidone antagonism of self-mutilation in a Lesch-Nyhan patient","volume":"20","author":"Allen","year":"1996","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2024.105847_bib3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF02172213","article-title":"Self-injury in lesch-nyhan disease","volume":"24","author":"Anderson","year":"1994","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.neubiorev.2024.105847_bib4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1468-1331.2001.00035.x","article-title":"Botulinum toxin type A and other botulinum toxin serotypes: a comparative review of biochemical and pharmacological actions","volume":"8","author":"Aoki","year":"2001","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neubiorev.2024.105847_bib5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF01098249","article-title":"Treatment of self-injury and disruptive behavior with carbamazepine (Tegretol) and behavior therapy","volume":"1","author":"Barrett","year":"1988","journal-title":"J. Multihandicap. Pers."},{"key":"10.1016\/j.neubiorev.2024.105847_bib6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0149-7634(85)90043-0","article-title":"The biochemical basis of the behavioral disorder in the Lesch-Nyhan syndrome","volume":"9","author":"Baumeister","year":"1985","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2024.105847_bib7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0149-7634(05)80036-3","article-title":"Pharmacologic control of aberrant behavior in the mentally retarded: Toward a more rational approach","volume":"14","author":"Baumeister","year":"1990","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2024.105847_bib8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nm1693","article-title":"Adenosine is crucial for deep brain stimulation\u2013mediated attenuation of tremor","volume":"14","author":"Bekar","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.neubiorev.2024.105847_bib9","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000449296","article-title":"Lesch-Nyhan syndrome: models, theories, and therapies","volume":"7","author":"Bell","year":"2016","journal-title":"Mol. Syndr."},{"key":"10.1016\/j.neubiorev.2024.105847_bib10","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.stemcr.2021.06.003","article-title":"Lesch-Nyhan disease causes impaired energy metabolism and reduced developmental potential in midbrain dopaminergic cells","volume":"16","author":"Bell","year":"2021","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.neubiorev.2024.105847_bib11","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1136\/jnnp.53.12.1096","article-title":"Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine","volume":"53","author":"Bottiglieri","year":"1990","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neubiorev.2024.105847_bib12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2165\/00003495-199448020-00002","article-title":"The clinical potential of ademetionine (S-adenosylmethionine) in neurological disorders","volume":"48","author":"Bottiglieri","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.neubiorev.2024.105847_bib13","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.braindev.2013.08.013","article-title":"Treatment of Lesch\u2013Nyhan disease with S-adenosylmethionine: experience with five young Malaysians, including a girl","volume":"36","author":"Chen","year":"2014","journal-title":"Brain Dev."},{"key":"10.1016\/j.neubiorev.2024.105847_bib14","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0006-8993(02)02654-9","article-title":"S-adenosylmethionine is substrate for carrier mediated transport at the blood\u2013brain barrier in vitro","volume":"942","author":"Chishty","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2024.105847_bib15","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1002\/mds.21723","article-title":"Antero-ventral internal pallidum stimulation improves behavioral disorders in Lesch-Nyhan disease","volume":"22","author":"Cif","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2024.105847_bib16","first-page":"95","article-title":"Pharmacologic evaluation of SCH-39166, A-69024, NO-0756, and SCH-23390 in neonatal-6-OHDA-lesioned rats. Further evidence that self-mutilatory behavior induced by L-dopa is related to D1 dopamine receptors","volume":"7","author":"Criswell","year":"1992","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2024.105847_bib17","first-page":"636","article-title":"Botulinum toxin as a novel treatment for self-mutilation in Lesch-Nyhan syndrome","volume":"47","author":"Dabrowski","year":"2005","journal-title":"Dev. Med Child Neurol."},{"key":"10.1016\/j.neubiorev.2024.105847_bib18","doi-asserted-by":"crossref","DOI":"10.1007\/s10143-023-01950-4","article-title":"Deep brain stimulation in Lesch-Nyhan syndrome: a systematic review","volume":"46","author":"Deng","year":"2023","journal-title":"Neurosurg. Rev."},{"key":"10.1016\/j.neubiorev.2024.105847_bib19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/0883073811415853","article-title":"Pallidal deep-brain stimulation associated with complete remission of self-injurious behaviors in a patient with lesch-nyhan syndrome","volume":"27","author":"Deon","year":"2012","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.neubiorev.2024.105847_bib20","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/INF.0b013e318287f02a","article-title":"Infectious complications of intrathecal baclofen pump devices in a pediatric population","volume":"32","author":"Dickey","year":"2013","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.neubiorev.2024.105847_bib21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00004714-200202000-00006","article-title":"Risperidone in the treatment of tourette syndrome: a double-blind, placebo-controlled trial","volume":"22","author":"Dion","year":"2002","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2024.105847_bib22","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/15257770.2013.774012","article-title":"Quantitative evaluation of the clinical effects of S -adenosylmethionine on mood and behavior in lesch-nyhan patients","volume":"32","author":"Dolcetta","year":"2013","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.neubiorev.2024.105847_bib23","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00702-020-02266-z","article-title":"Botulinum toxin therapy of dystonia","volume":"128","author":"Dressler","year":"2021","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neubiorev.2024.105847_bib24","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/BF01800605","article-title":"Bone marrow transplantation in Lesch-Nyhan disease","volume":"14","author":"Endres","year":"1991","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.neubiorev.2024.105847_bib25","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ymgme.2014.05.012","article-title":"Genotypic and phenotypic spectrum in attenuated variants of Lesch-Nyhan disease","volume":"112","author":"Fu","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.neubiorev.2024.105847_bib26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.pediatrneurol.2021.10.018","article-title":"Safety and efficacy of botulinum toxin in the treatment of self-biting behavior in lesch-nyhan disease","volume":"127","author":"Garcia-Romero","year":"2022","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.neubiorev.2024.105847_bib27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2788.1990.tb01529.x","article-title":"Dietary increase in serotonin reduces self-injurious behaviour in a Down\u2019s syndrome adult","volume":"34","author":"Gedye","year":"1990","journal-title":"J. Intellect. Disabil. Res."},{"key":"10.1016\/j.neubiorev.2024.105847_bib28","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0306-9877(92)90026-9","article-title":"Serotonin-GABA treatment is hypothesized for self-injury in Lesch-Nyhan syndrome","volume":"38","author":"Gedye","year":"1992","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.neubiorev.2024.105847_bib29","first-page":"133","article-title":"Reduction of self-mutilating behavior and improved oromotor function in a patient with Lesch-Nyhan syndrome following botulinum toxin injection: a case report","volume":"14","author":"Gilbert","year":"2021","journal-title":"J. Pedia Rehabil. Med"},{"key":"10.1016\/j.neubiorev.2024.105847_bib30","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2022-059574","article-title":"Ecopipam for tourette syndrome: a randomized trial","volume":"151","author":"Gilbert","year":"2023","journal-title":"Pediatrics"},{"key":"10.1016\/j.neubiorev.2024.105847_bib31","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF02395218","article-title":"Pharmacokinetics of S-adenosyl-L-methionine in healthy volunteers","volume":"27","author":"Giulidori","year":"1984","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.neubiorev.2024.105847_bib32","doi-asserted-by":"crossref","DOI":"10.1007\/s10545-006-0229-8","article-title":"Dramatic reduction in self-injury in Lesch\u2013Nyhan disease following S -adenosylmethionine administration","volume":"29","author":"Glick","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.neubiorev.2024.105847_bib33","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/mdc3.12040","article-title":"Consequences of delayed dental extraction in Lesch-Nyhan disease","volume":"1","author":"Goodman","year":"2014","journal-title":"Mov. Disord. Clin. Pr."},{"key":"10.1016\/j.neubiorev.2024.105847_bib34","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/jnc.12366","article-title":"Purine metabolism during neuronal differentiation: the relevance of purine synthesis and recycling","volume":"127","author":"G\u00f6ttle","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2024.105847_bib35","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/0278-5846(90)90090-4","article-title":"Pharmacotherapy for self-injurious behavior: preliminary tests of the D1 hypothesis","volume":"14","author":"Gualtieri","year":"1990","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2024.105847_bib36","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/WNF.0b013e31814a62cc","article-title":"Botulinum toxin: Treatment of self-mutilation in patients with Lesch-Nyhan syndrome","volume":"31","author":"Gutierrez","year":"2008","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.neubiorev.2024.105847_bib37","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.neubiorev.2017.02.027","article-title":"Self-injurious behavior","volume":"84","author":"Huisman","year":"2018","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.neubiorev.2024.105847_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11205981","article-title":"Oral self-mutilation in lesch-nyhan patients: a cross-sectional study","volume":"11","author":"Isola","year":"2022","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.neubiorev.2024.105847_bib39","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/mds.21063","article-title":"Tetrabenazine therapy of pediatric hyperkinetic movement disorders","volume":"21","author":"Jain","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2024.105847_bib40","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1242\/dmm.002543","article-title":"Lesch-Nyhan disease: from mechanism to model and back again","volume":"2","author":"Jinnah","year":"2009","journal-title":"Dis. Model Mech."},{"key":"10.1016\/j.neubiorev.2024.105847_bib41","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1093\/brain\/awl056","article-title":"Delineation of the motor disorder of Lesch\u2013Nyhan disease","volume":"129","author":"Jinnah","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2024.105847_bib42","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11011-012-9279-9","article-title":"Successful unrelated umbilical cord blood transplantation in Lesch-Nyhan syndrome","volume":"27","author":"K\u00e1llay","year":"2012","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neubiorev.2024.105847_bib43","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.brainres.2006.06.088","article-title":"Effect of N-acetylcysteine, allopurinol and vitamin E on jaundice-induced brain oxidative stress in rats","volume":"1111","author":"Karageorgos","year":"2006","journal-title":"Brain Res."},{"issue":"3943","key":"10.1016\/j.neubiorev.2024.105847_bib44","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1126\/science.169.3943.388","article-title":"Allopurinol: alteration in pyrimidine metabolism in man","volume":"169","author":"Kelley","year":"1970","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2024.105847_bib45","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ymgme.2016.04.012","article-title":"A double-blind, placebo-controlled, crossover trial of the selective dopamine D1 receptor antagonist ecopipam in patients with Lesch-Nyhan disease","volume":"118","author":"Khasnavis","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.neubiorev.2024.105847_bib46","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ymgme.2016.02.005","article-title":"A clinical trial of safety and tolerability for the selective dopamine D1 receptor antagonist ecopipam in patients with Lesch-Nyhan disease","volume":"117","author":"Khasnavis","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.neubiorev.2024.105847_bib47","article-title":"The effects of selective serotonin reuptake inhibitors on brain functional networks during goal-directed planning in obsessive\u2013compulsive disorder","volume":"10","author":"Kim","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neubiorev.2024.105847_bib48","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1023\/A:1022820124593","article-title":"Case report: The effects of selective serotonergic reuptake inhibitors combined with behavioral treatment on self-injury associated with Lesch-Nyhan syndrome","volume":"10","author":"Kirkpatrick-Sanchez","year":"1998","journal-title":"J. Dev. Phys. Disabil."},{"key":"10.1016\/j.neubiorev.2024.105847_bib49","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41576-018-0031-0","article-title":"Diagnosis and management of Cornelia de Lange syndrome: first international consensus statement","volume":"19","author":"Kline","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.neubiorev.2024.105847_bib50","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s12272-013-0057-y","article-title":"Implications and mechanism of action of gabapentin in neuropathic pain","volume":"36","author":"Kukkar","year":"2013","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.neubiorev.2024.105847_bib51","first-page":"51","article-title":"The Effect of S-adenosylmethionine on self-mutilation in a patient with Lesch-Nyhan disease","volume":"VOL 32","author":"Lauber","year":"2017"},{"key":"10.1016\/j.neubiorev.2024.105847_bib52","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.cmet.2019.09.001","article-title":"NAD+ in brain aging and neurodegenerative disorders","volume":"30","author":"Lautrup","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.neubiorev.2024.105847_bib53","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1042\/BST0340330","article-title":"S -Adenosylmethionine: jack of all trades and master of everything?","volume":"34","author":"Loenen","year":"2006","journal-title":"Biochem Soc. Trans."},{"key":"10.1016\/j.neubiorev.2024.105847_bib54","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1528-1157.1990.tb05371.x","article-title":"Adenosinergic modulation of homocysteine-induced seizures in mice","volume":"31","author":"Marangos","year":"1990","journal-title":"Epilepsia"},{"key":"10.1016\/j.neubiorev.2024.105847_bib55","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/S0022-510X(98)00199-3","article-title":"The natural history and the effects of gabapentin in amyotrophic lateral sclerosis","volume":"160","author":"Mazzini","year":"1998","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neubiorev.2024.105847_bib56","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJMoa013171","article-title":"Risperidone in children with autism and serious behavioral problems","volume":"347","author":"McCracken","year":"2002","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.neubiorev.2024.105847_bib57","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0887-8994(98)00166-0","article-title":"Gabapentin for self-injurious behavior in Lesch-Nyhan syndrome","volume":"20","author":"McManaman","year":"1999","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.neubiorev.2024.105847_bib58","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000502568","article-title":"The effect of S-adenosylmethionine treatment on neurobehavioral phenotypes in lesch-nyhan disease: a case report","volume":"11","author":"Momosaki","year":"2020","journal-title":"Case Rep. Neurol."},{"key":"10.1016\/j.neubiorev.2024.105847_bib59","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1212\/WNL.0000000000011597","article-title":"Systematic review of N-of-1 studies in rare genetic neurodevelopmental disorders","volume":"96","author":"M\u00fcller","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2024.105847_bib60","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/bmjebm-2017-110853","article-title":"Methodological quality and synthesis of case series and case reports","volume":"23","author":"Murad","year":"2018","journal-title":"BMJ Evid. Based Med"},{"key":"10.1016\/j.neubiorev.2024.105847_bib61","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2165\/00003088-198611050-00001","article-title":"Clinical pharmacokinetics of allopurinol","volume":"11","author":"Murrell","year":"1986","journal-title":"Clin. Pharmack."},{"key":"10.1016\/j.neubiorev.2024.105847_bib62","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ajoms.2021.02.010","article-title":"Combination of S-adenosylmethionine and mouthguard for oral self-mutilation in Lesch-Nyhan syndrome","volume":"33","author":"Narai","year":"2021","journal-title":"J. Oral\u00a0Maxillofac. Surg. Med. Pathol."},{"key":"10.1016\/j.neubiorev.2024.105847_bib63","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1017\/S0012162206002015","article-title":"Sudden Death in Lesch-Nyhan disease","volume":"48","author":"Neychev","year":"2006","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.neubiorev.2024.105847_bib64","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1146\/annurev.me.24.020173.000353","article-title":"The Lesch-Nyhan syndrome","volume":"24","author":"Nyhan","year":"1973","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.neubiorev.2024.105847_bib65","first-page":"167","author":"Nyhan","year":"1986","journal-title":"Bone Marrow Transplant. Lesch-Nyhan Dis."},{"key":"10.1016\/j.neubiorev.2024.105847_bib66","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1177\/0145445500242003","article-title":"A review of behavioral treatments used for lesch-nyhan syndrome","volume":"24","author":"Olson","year":"2000","journal-title":"Behav. Modif."},{"key":"10.1016\/j.neubiorev.2024.105847_bib67","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0002-9343(96)00381-6","article-title":"Gabapentin for parkinsonism: a double-blind, placebo-controlled, crossover trial","volume":"102","author":"Olson","year":"1997","journal-title":"Am. J. Med."},{"key":"10.1016\/j.neubiorev.2024.105847_bib68","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.neubiorev.2024.105847_bib69","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/0020-711X(89)90159-6","article-title":"Purine nucleotide production in normal and HPRT- cells","volume":"21","author":"Page","year":"1989","journal-title":"Int. J. Biochem."},{"key":"10.1016\/j.neubiorev.2024.105847_bib70","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/978-1-4615-2584-4_76","article-title":"Treatment of Lesch-Nyhan Syndrome with AICAR","author":"Page","year":"1995","journal-title":": Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neubiorev.2024.105847_bib71","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10803-006-0234-7","article-title":"Risperidone improves behavioral symptoms in children with autism in a randomized, double-blind, placebo-controlled trial","volume":"37","author":"Pandina","year":"2007","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.neubiorev.2024.105847_bib72","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/ner.12261","article-title":"Remarkable clinical improvement with bilateral globus pallidus internus deep brain stimulation in a case of Lesch-Nyhan disease: Five-year follow-up","volume":"18","author":"Piedimonte","year":"2015","journal-title":"Neuromodulation"},{"key":"10.1016\/j.neubiorev.2024.105847_bib73","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-014-0208-3","article-title":"Treatment of motor and behavioural symptoms in three Lesch-Nyhan patients with intrathecal baclofen","volume":"9","author":"Pozzi","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.neubiorev.2024.105847_bib74","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.neucli.2005.12.004","article-title":"Electrophysiological characteristics of limbic and motor globus pallidus internus (GPI) neurons in two cases of Lesch-Nyhan syndrome","volume":"35","author":"Pralong","year":"2005","journal-title":"Neurophysiol. Clin."},{"key":"10.1016\/j.neubiorev.2024.105847_bib75","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/sj.sc.3100366","article-title":"Effectiveness of gabapentin in controlling spasticity: a quantitative study","volume":"35","author":"Priebe","year":"1997","journal-title":"Spinal Cord."},{"key":"10.1016\/j.neubiorev.2024.105847_bib76","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1521\/suli.2008.38.5.498","article-title":"Single-case experimental designs for the evaluation of treatments for self-injurious and suicidal behaviors","volume":"38","author":"Rizvi","year":"2008","journal-title":"Suicide Life Threat Behav."},{"key":"10.1016\/j.neubiorev.2024.105847_bib77","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1177\/088307389601100613","article-title":"Carbamazepine trial for Lesch-Nyhan self-mutilation","volume":"11","author":"Roach","year":"1996","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.neubiorev.2024.105847_bib78","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neubiorev.2020.09.001","article-title":"Psychological mechanisms and functions of 5-HT and SSRIs in potential therapeutic change: Lessons from the serotonergic modulation of action selection, learning, affect, and social cognition","volume":"119","author":"Roberts","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2024.105847_bib79","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1469-8749.2003.tb00925.x","article-title":"Modes and patterns of self-mutilation in persons with Lesch-Nyhan disease","volume":"45","author":"Robey","year":"2003","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.neubiorev.2024.105847_bib80","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1469-8749.2003.tb00925.x","article-title":"Modes and patterns of self-mutilation in persons with Lesch-Nyhan disease","volume":"45","author":"Robey","year":"2007","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.neubiorev.2024.105847_bib81","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.132094","article-title":"Rescuing compounds for Lesch-Nyhan disease identified using stem cell-based phenotypic screening","volume":"5","author":"Ruillier","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.neubiorev.2024.105847_bib82","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1016\/S0387-7604(00)00143-1","article-title":"Neurotransmitter changes in the pathophysiology of Lesch-Nyhan syndrome","volume":"22","author":"Saito","year":"2000","journal-title":"Brain Dev."},{"key":"10.1016\/j.neubiorev.2024.105847_bib83","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000014034","article-title":"Xanthine oxidoreductase gene expression and enzyme activity in developing human tissues","volume":"74","author":"Saksela","year":"1998","journal-title":"Neonatology"},{"key":"10.1016\/j.neubiorev.2024.105847_bib84","article-title":"Intrathecal baclofen therapy for Lesch-Nyhan disease: illustrative case","volume":"1","author":"Satow","year":"2021","journal-title":"J. Neurosurg.: Case Lessons"},{"key":"10.1016\/j.neubiorev.2024.105847_bib85","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1469-8749.2005.tb01052.x","article-title":"Behavioral aspects of Lesch-Nyhan disease and its variants","volume":"47","author":"Schretlen","year":"2007","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.neubiorev.2024.105847_bib86","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/mds.21786","article-title":"Levodopa therapy in a Lesch-Nyhan disease patient: pathological, biochemical, neuroimaging, and therapeutic remarks","volume":"23","author":"Serrano","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2024.105847_bib87","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1212\/WNL.0000000000002560","article-title":"Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache","volume":"86","author":"Simpson","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2024.105847_bib88","first-page":"28","article-title":"Self-mutilation and pharmacotherapy","volume":"2","author":"Smith","year":"2005","journal-title":"Psychiatry (Edgmont)"},{"key":"10.1016\/j.neubiorev.2024.105847_bib89","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.neubiorev.2024.105847_bib90","first-page":"414","article-title":"Disappearance of self-mutilating behavior in a patient with lesch-nyhan syndrome after bilateral chronic stimulation of the globus pallidus internus","volume":"98","author":"Taira","year":"2003","journal-title":"Case Rep. J. Neurosurg."},{"key":"10.1016\/j.neubiorev.2024.105847_bib91","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/ner.13217","article-title":"Deep brain stimulation of the internal pallidum in Lesch\u2013Nyhan syndrome: clinical outcomes and connectivity analysis","volume":"24","author":"Tambirajoo","year":"2021","journal-title":"Neuromodulation"},{"key":"10.1016\/j.neubiorev.2024.105847_bib92","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0920-1211(97)00084-3","article-title":"A summary of mechanistic hypotheses of gabapentin pharmacology","volume":"29","author":"Taylor","year":"1998","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neubiorev.2024.105847_bib93","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/21678707.2019.1652597","article-title":"Current understanding of Lesch-Nyhan disease and potential therapeutic targets","volume":"7","author":"Torres","year":"2019","journal-title":"Expert Opin. Orphan Drugs"},{"key":"10.1016\/j.neubiorev.2024.105847_bib94","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.metabol.2007.04.013","article-title":"Efficacy and safety of allopurinol in patients with hypoxanthine-guanine phosphoribosyltransferase deficiency","volume":"56","author":"Torres","year":"2007","journal-title":"Metabolism"},{"key":"10.1016\/j.neubiorev.2024.105847_bib95","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.stem.2023.04.011","article-title":"Human pluripotent-stem-cell-derived organoids for drug discovery and evaluation","volume":"30","author":"Vandana","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.neubiorev.2024.105847_bib96","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0165-0173(99)00094-6","article-title":"Lesch\u2013Nyhan disease and the basal ganglia","volume":"32","author":"Visser","year":"2000","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neubiorev.2024.105847_bib97","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/mds.23478","article-title":"Levodopa is not a useful treatment for Lesch-Nyhan disease","volume":"26","author":"Visser","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2024.105847_bib98","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/dmcn.14852","article-title":"Deep brain stimulation in Lesch\u2013Nyhan disease: outcomes from the patient\u2019s perspective","volume":"63","author":"Visser","year":"2021","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.neubiorev.2024.105847_bib99","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.pediatrneurol.2024.03.020","article-title":"Very early levodopa may prevent self-injury in lesch-nyhan disease","volume":"155","author":"Visser","year":"2024","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.neubiorev.2024.105847_bib100","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13754","article-title":"Oral nicotinamide riboside raises NAD+ and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin","volume":"22","author":"Vreones","year":"2023","journal-title":"Aging Cell"},{"key":"10.1016\/j.neubiorev.2024.105847_bib101","doi-asserted-by":"crossref","first-page":"8675","DOI":"10.1038\/s41598-017-09077-5","article-title":"Treatment associated changes of functional connectivity of midbrain\/brainstem nuclei in major depressive disorder","volume":"7","author":"Wagner","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neubiorev.2024.105847_bib102","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1023\/A:1020661514514","article-title":"Bone marrow transplantation does not ameliorate the neurologic symptoms in mice deficient in hypoxanthine guanine phosphoribosyl transferase (HPRT)","volume":"14","author":"Wojcik","year":"1999","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neubiorev.2024.105847_bib103","first-page":"44","article-title":"The effect of methionine and S-adenosylmethionine on S-adenosylmethionine levels in the rat brain","volume":"30","author":"Young","year":"2005","journal-title":"J. Psychiatry Neurosci."}],"container-title":["Neuroscience &amp; Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763424003166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763424003166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T23:55:35Z","timestamp":1733097335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763424003166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":103,"alternative-id":["S0149763424003166"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2024.105847","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of neurological symptoms in Lesch-Nyhan disease: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2024.105847","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105847"}}